Keyphrases
Monotherapy
100%
PARP Inhibitor (PARPi)
100%
Real-world Outcomes
100%
Primary Advanced Ovarian Cancer
100%
Active Surveillance
55%
Real-world Progression-free Survival
33%
Tumor
22%
Chemotherapy
22%
Improved Outcomes
11%
Homologous Recombination Deficiency
11%
Kaplan-Meier Method
11%
Patient Demographics
11%
Statistical Analysis
11%
Treatment Outcome
11%
Cox Model
11%
Advanced Ovarian Cancer
11%
Population Data
11%
Treatment Patterns
11%
Maintenance Treatment
11%
Real-world Population
11%
Treatment Uptake
11%
Time to Next Treatment
11%
Homologous Recombination Proficient
11%
BRCA Wild-type
11%
Real-time Database
11%
Medicine and Dentistry
Monotherapy
100%
Ovarian Cancer
100%
PARP Inhibitor
100%
Progression Free Survival
33%
Neoplasm
22%
Homologous Recombination
22%
Diseases
22%
Proportional Hazards Model
11%
Kaplan Meier Method
11%
Maintenance Therapy
11%
Pharmacology, Toxicology and Pharmaceutical Science
Monotherapy
100%
Ovary Cancer
100%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor
100%
Progression Free Survival
33%
Neoplasm
22%
Chemotherapy
22%
Diseases
22%